The purpose of this study was to determine the demographics, histology, met
hods of treatment, and survival in primary mediastinal malignancies. We did
a retrospective review of the statewide New Mexico Tumor Registry for all
malignant tumors treated between January 1, 1973 and December 31, 1995. Ben
ign tumors and cysts of the mediastinum were excluded. Two hundred nineteen
patients were identified from a total of 110,284 patients with primary mal
ignancies: 55% of tumors were lymphomas, 16% malignant germ cell tumors, 14
% malignant thymomas, 5% sarcomas, 3% malignant neurogenic tumors, and 7% o
ther tumors. There were significant differences in gender between histologi
es (P < 0.001). Ninety-four percent of germ cell tumors occurred in males,
66% of neurogenic tumors were in females; other tumors occurred in males in
58% of cases. There were also significant differences in ages by histology
(P < 0.001). Neurogenic tumors were most common in the first decade, lymph
omas and germ cell tumors in the second to fourth decades, and lymphomas an
d thymomas in patients in their fifth decades and beyond. Stage at presenta
tion (P = 0.001) and treatment (P < 0.001) also differed significantly betw
een histologic groups. Five-year survival was 54% for lymphomas, 51% for ma
lignant germ cell tumors, 49% for malignant thymomas, 33% for sarcomas, 56%
for neurogenic tumors, and 51% overall. These survival rates were not stat
istically different (P > 0.50). Lymphomas, malignant germ cell tumors, and
thymomas were the most frequently encountered malignant primary mediastinal
neoplasms in this contemporary series of patients. Demographics, stage at
presentation, and treatment modality varied significantly by histology. Des
pite these differences, overall five-year survival was not statistically di
fferent.